ABSTRACT FOXL2, a winged-helix/forkhead domain transcription factor, is a key gene involved in the differentiation and biological functions of the ovary. In a recent transcriptomic analysis, we found that FOXL2 expression in bovine caruncular endometrium was different from that in intercaruncular endometrium. In order to gain new insights into FOXL2 in this tissue, we determined the expression of this transcription factor during the estrous cycle and the establishment of pregnancy in cattle. The endometrial expression of FOXL2 did not vary during maternal recognition of pregnancy . Using an in vivo bovine model and primary cell cultures, we showed that FOXL2 was not an interferon-tau target gene. Both FOXL2 transcript and protein were expressed from Day 5 to Day 20 of the estrous cycle, and their levels showed a significant increase during the luteolytic phase. A 2-day progesterone supplementation in heifers led to a clear down-regulation of FOXL2 protein levels, suggesting the negative impact of progesterone on FOXL2 expression. Immunohistochemistry data revealed the localization of FOXL2 in endometrial stromal and glandular cells. FOXL2 subcellular distribution was shown to be nuclear in endometrial samples collected during the luteolytic period, while it was not detected in nuclei during the luteal phase and at implantation. Collectively, our findings provide the first evidence that FOXL2 is involved in the regulation of endometrial tissue physiology.
INTRODUCTION
In mammals, implantation represents a critical checkpoint for the success of pregnancy [1] . This step corresponds to the establishment of permanent cellular interactions between the conceptus (embryonic disk and extraembryonic tissues) and the endometrium [2] . Compared to the invasive nature of implantation in mice and humans, the process of implantation is superficial in ruminants, leading to a synepitheliochorial placentation [3] . In these domestic species, progesterone (P4) and interferon-tau (IFNT) represent two major factors regulating endometrial physiology during the establishment of pregnancy [4] . In sheep and cattle, P4 is indispensable for supporting pregnancy, and alterations in circulating P4 concentration have been reported to significantly affect conceptus elongation as well as endometrial gene expression patterns [5] [6] [7] [8] [9] . In these species, IFNT has been shown to be the major signal for maternal recognition of pregnancy [10] . The spatiotemporal secretion of IFNT is restricted to the trophectoderm during the elongation phase of the conceptus [11] . Experimental models and cell lines have been used to show that IFNT inhibits luteolytic mechanisms and induces expression of IFNT-stimulated genes in the endometrium [7, [12] [13] [14] , circulating immune cells [15] , and, more recently, in the corpus luteum during the peri-implantation period [16] .
Recent high-throughput data have highlighted the major impact of the conceptus on ovine and bovine endometrial physiology during the peri-implantation period of pregnancy [1, 14] . The endometrial response in small aglandular areas of endometrium (caruncles [CAR] ) has also been shown to differ from that in large glandular intercaruncular (ICAR) areas [13, 17, 18] . These transcription profiles have revealed the expression of several families of transcription factors including the forkhead box containing transcription factors (FOX) family [13, 17, 18] . The FOX family represents more than 40 transcription factors whose biological functions are essentially related to organ development, aging, metabolic and immunoregulatory processes, cell cycling, and cancer [19] [20] [21] . In the context of the endometrium, murine Foxa2 and human FOXO1A have been shown to be involved in gland development and differentiation of stroma cells and in decidualization [22] [23] [24] . In addition to these two FOX factors [13, 18] , several other FOX factors including FOXC1, FOXL2, and FOXQ1 have been identified in high-throughput analyses of bovine endometrium. Very interestingly, FOXL2 expression in CAR is different from that in ICAR tissue on Day 20 day of the estrous cycle [13] . Originally, FOXL2 expression had been restricted to three cell types, namely granulosa cells in the fetal and adult ovary, anterior pituitary cells, and fetal eyelid cells [25, 26] . FOXL2 was first cloned 10 years ago in humans [27] , and it was subsequently isolated in a large variety of animal species ranging from invertebrates (e.g., sea urchins and oysters [28, 29] ) to fish, chickens, mice, and goats [30] [31] [32] . In vertebrates, including livestock, FOXL2 has been reported to be a key gene for ovarian differentiation [26, [32] [33] [34] [35] [36] . In addition, FOXL2 has been shown to control GnRH receptor expression [37] , regulate gonadotropin hormone secretion (follicle-stimulating and luteinizing hormones) in the anterior pituitary [25, 38] , and control ovarian function by acting on ovarian differentiation, steroid secretion, ovulation, stress response, and hormone metabolism [34, [38] [39] [40] . The present study was conducted to evaluate the expression and regulation of FOXL2 during the estrous cycle and early pregnancy and the effect of P4 and IFNT on FOXL2 gene expression and cell localization in bovine endometrium.
MATERIALS AND METHODS

Animals and Cell Cultures
All experiments were conducted in accordance with the International Guiding Principles for Biomedical Research Involving Animals, as promulgated by the Society for the Study of Reproduction.
Experiment 1: FOXL2 expression during the period of pregnancy recognition. Cyclic and pregnant cross-bred beef heifers were synchronized and artificially inseminated as previously described [12] . The day of estrus was considered Day 0. Heifers were slaughtered at Day 16 (cyclic: n ¼ 5; pregnant: n ¼ 4) and at Day 20 (cyclic: n ¼ 6; pregnant: n ¼ 5). Uteri were collected, flushed, and, when present, recovered concepti were observed by microscopy to confirm the stage of development [41] . From pregnant and cyclic animals, endometrial CAR and ICAR areas were dissected from the uterine horns ipsilateral to the corpus luteum as previously described [13] .
Cyclic and early pregnant Charolais cows were produced using the CRESTAR method and artificial insemination, as previously published [42] . The day of estrus was considered Day 0, and females were slaughtered at Day 20 (cyclic: n ¼ 5; pregnant: n ¼ 5). Uteri were collected and dissected as described above. In addition, ovaries with the corpus luteum were collected. Some follicles and the corpus luteum were dissected.
Experiment 2: impact of in vitro and in vivo IFNT infusion on FOXL2 endometrial expression. The estrous cycles of cyclic cows (Charolais breed) were synchronized as described above. The uterine lumen was infused with recombinant ovine IFNT (roIFNT; 200 lg/ml; 25 ml/horn) or control solution (saline buffer) at Day 14 postestrus as we previously described [12] . The endometria of 6 females infused with IFNT and 5 control animals were collected and dissected as described in experiment 1.
Culturing of bovine endometrial cells (fibroblasts or glandular epithelial cells) was carried out as we previously reported [12, 13] , and samples were treated for 2 h or 24 h with 100 ng/ml roIFNT [12, 13] .
Experiment 3: impact of P4 supplementation on FOXL2 expression. Cyclic heifers and those confirmed to be pregnant (by artificial insemination) received a P4-releasing intravaginal device containing 1.55 g of progesterone (Ceva Animal Health Ltd.) on Day 3 of the estrous cycle or pregnancy to increase circulating concentrations of P4 as previously published [6, 43] . Strips of endometrium (CAR and ICAR) were sampled after 2 days and 13 days of P4 supplementation (Days 5 and 16, respectively) in cyclic and pregnant females displaying normal and high concentrations of P4.
Tissue Collection, Preparation for Immunohistochemistry, and RNA Extraction Endometrial samples were immediately snap frozen in liquid nitrogen and stored at À808C prior to analysis [13] . At the same time, sections of the ipsilateral uterine horn were fixed in 4% paraformaldehyde in phosphate buffer and then washed in 13 PBS, followed by a 12-h dehydration treatment in a Shandon Citadel 1000 tissue processor (Thermo-electron Corp.) using increasing concentrations of ethanol. Tissues were embedded in paraffin (Paraplast plus, McCormick Scientific, VWR) and subsequently stored at 48C. Whole uterus cross-sections were cut (7 lm) with a rotary microtome (Leica model RM2245) and stored at room temperature until processed. Total RNA from frozen tissue was isolated by homogenization using TRIzol reagent (Invitrogen) as published previously [13] . All RNA samples were purified using Qiagen columns integrating a DNase step (RNeasy mini-kit; Qiagen). Quality and integrity of total extracted and purified RNA were determined using an Agilent 2100 bioanalyzer. Upon addition of RNase inhibitor (RNasine; Promega) total RNA was stored at À808C.
Real-Time RT-PCR
Purified total RNA samples were used for quantitative RT-PCR (RTqPCR). One microgram of total RNA was reverse transcribed into cDNA with Superscript II enzyme (Invitrogen) in a 20-ll volume. RT-PCR reactions were carried out with Master Mix SYBR Green and Step One Plus system (Applied Biosystems). Primers (Eurogentec) were designed (Primer Express version 2.0 software; Applied Biosystems) to specifically amplified bovine FOXL2 (forward: CCGGCATCTACCAGTACATTATAGC; and reverse: G C A C T C G T T G A G G C T G A G G T [ N C B I s e q u e n c e r e f e r e n c e , NM_001031750.1]) and RPL19 (forward: CCCCAATGAGACCAAT-GAAATC; and reverse: CAGCCCATCTTTGATCAGCTT) [13] . Amplified FOXL2 and RPL19 PCR fragments were sequenced to assess amplification of the correct fragment. According to the relative standard curve method [44] , quantification of the amount of FOXL2 mRNA relative to that of the RPL19 normalizer gene was calculated.
Western Blot Analysis
Frozen tissues (bovine ovary and endometrium) were ground in liquid nitrogen and then resuspended with radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris HCl [pH 8], 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, anti-protease [Roche]; 200 ll of RIPA buffer per 100 lg of tissue) in a Dounce homogenizer on ice. Samples were centrifuged at 20 000 3 g for 5 min at 48C, and then the supernatant corresponding to the total protein extract was collected and stored at À808C. Protein quantification was carried out using the Bradford method with bovine serum albumin (BSA) as the standard (Sigma-Aldrich).
Western blot immunoassays were processed with 25 lg of total protein extract lysed in SDS buffer and separated using 4%-12% NuPage bis-Tris gel electrophoresis (Novex; Invitrogen). Protein molecular mass markers (Novex Sharp protein standard, 3.5-260 kDa; Invitrogen) were run simultaneously as molecular mass standards. Electrophoretically separated polypeptides were transferred onto a Hybond-P polyvinylidene fluoride membrane (Amersham). Membranes were blocked in 1:1000 Tween 20-PBS (PBS-T, Euromedex) containing 4% (w/v) non-fat dried milk. Membranes were probed with a rabbit anti-FOXL2 purified antibody generated against a peptide corresponding to the C-terminal conserved region of mammalian FOXL2 (WDHDSKTGALHSRLDL; diluted 1:500; Caslo Laboratory) in PBS-T solution containing 4% non-fat dry milk. Then, membranes were incubated with a goat peroxidase-conjugated anti-rabbit immunoglobulin G (IgG) antibody (diluted 1:5000; Santa Cruz Biotechnology). Actin B (ACTB) was assessed as a loading control, using a mouse monoclonal anti-ACTB antibody (diluted 1:2000; Sigma-Aldrich) and goat peroxidase-conjugated anti-mouse IgG antibody (diluted 1:5000; Santa Cruz Biotechnology). Immunoreaction signals were revealed with ECL Plus Western blotting detection reagents (Amersham) and analyzed using an image analysis system (Advanced Image Data Analyzer software; LAS 1000 camera; Fujifilm).
Immunohistochemistry
Sections were rehydrated in xylene (Prolabo; VWR), followed by ethanol baths of decreasing concentration. Sections were incubated in citrate buffer (sodium citrate, 0.01M, pH 6.0) at room temperature for 5 min, followed by incubation at 808C for an additional 10 min to unmask sections. Endogenous peroxidase activity was quenched by treatment with 0.1% hydrogen peroxide for 30 min. Sections were then incubated with a rabbit anti-FOXL2 purified antibody (diluted 1:100; Caslo Laboratory) or a goat polyclonal anti-lamin B (Lamin B) antibody (diluted 1:200; Santa Cruz Biotechnology) in phosphate buffer (0.1 M, pH 7.4, with 2% BSA and 1% normal donkey serum) at 48C overnight. As a negative control, the peptide used to generate the antibody was co-incubated with the rabbit anti-FOXL2 purified antibody at 378C for 1 h before incubation on sections. After several washes in phosphate buffer with 2% BSA, anti-rabbit biotinylated antibody (diluted 1:500; Jackson ImmunoResearch) and anti-goat biotinylated antibody (diluted 1:200; Santa Cruz Biotechnology) were applied to slides for 1 h at room temperature. After three washes in phosphate buffer, sections were incubated for 1 h with the ABC Vector Elite kit (Vectastain Elite ABC kit; Vector Labs) in Trisbuffer (Tris 50 mM, NaCl 0.15 M, pH 7.5). Slides were washed three times and incubated with diaminobenzidine substrate and urea (Fast 3.3; Sigma) in Tris-buffer for 2-10 min, until brown staining was detectable. After one wash in water, slides were dehydrated by immersion in increasing concentrations of ethanol baths and then mounted with Eukit mounting medium (Sigma). A section for each physiological condition was stained with hematoxylin-eosin solution to highlight tissue morphology. Images were obtained using a NanoZoomer digital pathology system and then analyzed using NanoZoomer digital pathology virtual slide viewer (NDPView software; Hamamatsu). Each experiment was repeated with four different uterine cross-sections for each animal (three females per biological condition). Quantification of immunohistochemistry staining was processed using ImageJ version 1.45 software (National Institutes of Health, Bethesda, MD; http://rsbweb.nih.gov/ij/). EOZENOU ET AL.
Statistical Analyses
Statistical analyses were carried out using GraphPad Prism 4 software (GraphPad Software). Quantitative data were subjected to a two-way ANOVA followed by Bonferroni test. For female tissues collected on Days 5, 16, and 20, data were analyzed for the effects of day, pregnancy status (cyclic or pregnant), endometrial areas (CAR and ICAR), and their interactions (day versus status or status versus endometrial areas). Linear regression analysis was used to correlate circulating P4 concentrations with FOXL2 protein expression.
RESULTS
FOXL2 Is Regulated During the Estrous Cycle in Bovine Endometrium
In cattle, the estrous cycle lasts 20-22 days and is associated with an increase in progesterone secretion (Day 3-4) that reaches a plateau before decreasing (Day 18) in association with corpus luteum regression. FOXL2 transcript expression was significantly higher in cyclic heifers on Day 20 when this expression was compared to pregnant heifers on Day 20 and cyclic and pregnant heifers on Day 16 (2.7-to 3.3-fold in CAR area and 2.2-to 3.2-fold in ICAR area; Fig. 1A , P , 0.01). However, in CAR and ICAR areas, endometrial expression of FOXL2 mRNA did not significantly differ between Day 16 and Day 20 in pregnant heifers. At the protein level, a similar pattern of FOXL2 regulation was reported in CAR and ICAR endometrial areas, with significantly higher FOXL2 expression in cyclic females on Day 20 (1.5-to 2.2-fold higher) than other conditions (P , 0.05) (Fig. 1B) . Similar results were obtained with Charolais cows analyzed on Day 20 of the estrous cycle and pregnancy (Supplemental Fig. S1 ; all Supplemental Data 
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are available online at www.biolreprod.org). In the ovary (Supplemental Fig. S1B ) as well as endometrial CAR and ICAR areas (Fig. 1B) , the apparent molecular mass of FOXL2 (;50 kDa) was similar to and consistent with those reported in other animal species [31, 32, 45] . Expression of FOXL2 mRNA and protein levels were significantly lower in ICAR areas than in CAR areas ( P , 0.05) ( Fig. 1 ; also see Supplemental Fig.  S1 ).
FOXL2 endometrial expression appeared to be downregulated during the implantation period. In order to analyze the impact of IFNT (the major signal of maternal recognition of pregnancy in cattle) on FOXL2 expression, an experimental bovine model was derived using an intrauterine infusion of roIFNT in cyclic cows on Day 14 of the estrous cycle (luteal phase). The amount of endometrial FOXL2 transcript differed significantly between CAR and ICAR areas, but the short-term IFNT treatment (2 h) did not significantly affect FOXL2 transcript or protein levels (Fig. 2, A and B) .
Bovine endometrial cell cultures (fibroblasts and glandular epithelial cells) were treated with roIFNT in order to investigate the differences between short-term (2-h) and longterm (24-h) treatment with IFNT. Glandular epithelial cells displayed a lower expression of FOXL2 mRNA than fibroblasts (2 h, 3-fold; 24 h, 5-fold; P , 0.05). The short-term (2-h) and long-term treatment (24-h) of IFNT did not significantly alter FOXL2 expression level (Fig. 2C ).
Increased Concentration of Progesterone Affects Endometrial FOXL2 Expression In Vivo
Considering the variation in FOXL2 gene expression according to the stage of estrous cycle, we addressed the question of FOXL2 regulation in an experimental bovine model with increased concentrations of circulating P4 induced by exogenous supplementation.
In heifers supplemented with P4 for 48 h (Day 3-5) compared with control animals, a significant 2.55-fold decrease in endometrial FOXL2 expression was detected in cyclic heifers (P , 0.05) (Fig. 3A) . The lack of significance in pregnant animals was a consequence of the limited number of samples (n ¼ 2). No significant impact of P4 treatment was detected in pregnant or cyclic heifers sampled on Day 16 following 13-day steroid hormone supplementation (Fig. 3A) . Nevertheless, a lower FOXL2 expression was observed in endometrial tissue samples collected from cyclic and pregnant heifers on Day 16 compared with those collected on Day 5 (P , 0.05) (Fig 3A) . Interestingly, when circulating concentrations of P4 were plotted against FOXL2 endometrial expression, the amount of FOXL2 protein was shown to be inversely correlated with blood concentrations of P4 (P ¼ 0.0201) (Fig. 3B) .
Cellular Localization of FOXL2 Varies in Bovine Endometrium Collected at Two Different Stages of the Estrous Cycle and at Implantation
The specificity of FOXL2 antibody was confirmed using bovine ovarian tissue and blocking peptide (Supplemental Fig.  S2, A and B) . In keeping with published data in other vertebrates [46] , FOXL2 was clearly localized in nuclei of granulosa cells surrounding the antral follicle (Supplemental Fig. S2A ). In the endometrium, FOXL2 cell localization was investigated in cyclic cows on Day 14 (luteal phase) and Day 20 (follicular phase) as well as in pregnant cows at the time of initiation of implantation (Fig. 4, Day 20) . The intracellular position of nuclei in the various endometrial cell populations was determined using hematoxylin-eosin staining (Fig. 4I) or anti-Lamin B antibody (Supplemental Fig. S2, C and D) . On Days 14 and 20 of the estrous cycle, FOXL2 was clearly detected in stroma cells, superficial and deep glandular epithelium, and endothelial cells of blood vessels (Fig. 4, A, 
FIG. 2. Regulation of FOXL2 gene expression by IFNT.
A and B) CAR and ICAR endometrial areas were collected from Charolais cows infused with control solution (n ¼ 5) or roIFNT (200 lg/ml; n ¼ 6) for 2 h. A) Quantification of FOXL2 mRNA by RT-qPCR. Expression of FOXL2 transcript was normalized to that of RPL19. B) Quantification of FOXL2 protein by Western blotting. FOXL2 expression was normalized to that of ACTB protein level. C) Regulation of FOXL2 expression by IFNT in bovine endometrial primary cell cultures (stroma and glandular epithelium cell culture) was investigated using RT-qPCR. Expression of FOXL2 was normalized to that of RPL19. Quantitative data are means 6 SEM.
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B, D, and E). Nevertheless, intracellular FOXL2 localization differed between the two stages of the estrous cycle as FOXL2 nuclear staining was restricted to stroma cells on Day 14 (Fig.  4D ) but was visible in stroma and glandular epithelial cells on Day 20 (Fig. 4E) . Intrauterine infusion of IFNT did not affect FOXL2 cell localization compared with endometrium collected on Day 14 (Fig. 4G) . In pregnant cows at Day 20, endometrial FOXL2 was observed in stroma, glandular, and endothelial cells, but none of these cells displayed a detectable nuclear localization (Fig. 4, C and F) . Regardless of physiological condition, staining of luminal epithelium appeared negative for FOXL2. Quantification of immunohistochemistry staining confirmed that FOXL2 expression displayed significant differences among physiological stages in glandular and stroma cells (Fig. 4J) . On Day 20 in cyclic endometrium, FOXL2 staining was significantly higher in stroma and glandular cells than on Day 14 cyclic and Day 20 pregnant tissue. However, at 20 days of pregnancy, stromal FOXL2 expression was significantly lower than in both cyclic stages. Quantification of the FOXL2 intensity signal was in keeping with quantification of the FOXL2 expression on Days 16 and 20 in cyclic and pregnant endometrium (Fig. 1B) .
DISCUSSION
FOXL2 has been recognized as a key factor involved in ovarian development and biological functions from fetal life to adulthood [47, 48] . Recently, FOXL2 was listed as a gene whose expression in CAR endometrium differed from that in ICAR endometrium sampled from cyclic females on Day 20 [13] . In the current study, we demonstrated that FOXL2 is expressed in the endometrium and regulated during the estrous cycle and the period of maternal recognition of pregnancy.
Compared with the early preimplantation phase (Day 5), a clear decrease in FOXL2 transcript and protein expression levels was detected during the period of maternal recognition of pregnancy and implantation (Days [16] [17] [18] [19] [20] . FOXL2 gene expression was not influenced by the conceptus, and short-term infusion of IFNT (the major pregnancy recognition signal in ruminants [10, 14] ) affected neither FOXL2 expression nor its cell localization. Similarly, treatment of endometrial cells with IFNT for 2 h or 24 h did not affect FOXL2 mRNA expression. Collectively, our data do not support the hypothesis that the conceptus contributes to the regulation of FOXL2 expression in bovine endometrium. This situation differs from that in humans in which a negative impact of trophoblast tissue on FOXL2 expression has been reported in endometrial stromal cells using a 24-h coculture cell system and gene expression profiling [49] . The down-regulation of FOXL2 expression has also been reported in human endometrial stromal cells co-incubated for 12 h with trophoblast-conditioned medium compared to control conditioned medium [50] . Therefore, experimental data using in vitro human models support the negative effect of trophoblast secretions on FOXL2 expression regardless of P4 action [49, 50] . Type of implantation as well as embryo signals differ between cattle and humans [2] , and additional studies across animal species will be necessary to understand the relationships among conceptus secretions, type of implantation, and endometrial regulation of FOXL2 gene expression.
Progesterone is a major hormone of pregnancy, whose biological actions are crucial for the establishment and maintenance of pregnancy in ruminants and in mammals generally [51] . During the estrous cycle, the endometrial expression of FOXL2 decreases between Day 5 and Day 16 (early luteal and late luteal phases, respectively), following which it increases from Day 16 to Day 20 (follicular phase). The endometrial pattern of FOXL2 expression appears to be inversely related to the circulating P4 concentrations determined at similar stages [43, 52] . Furthermore, a two-day P4 supplementation (Days 3-5) led to a significant reduction in FOXL2 expression in both cyclic and pregnant heifers at Day 5. Very interestingly, microarray experiments carried out with human endometrium have also indicated a variable expression of endometrial FOXL2 mRNA across the menstrual cycle in women [53] . During the proliferative phase, FOXL2 expression was high, whereas it dropped during the secretory phase, a period associated with high luteal P4 secretion and a lower EOZENOU ET AL. production of estradiol [53] . Therefore, FOXL2 appears to be expressed in human endometrium and regulated by ovarian steroid balance. Collectively, these data and our results strongly suggest that FOXL2 gene expression is negatively regulated by P4 in mammals, and they suggest the need for a detailed regulation of this transcription factor by steroids.
In our study, changes in FOXL2 expression level were associated with distinct patterns of cell and subcellular localization throughout the estrous cycle and at the initiation of implantation. In endometrium sampled from cyclic cows during the luteal (Day 14) and follicular (Day 20) phases, FOXL2 was always detectable in the nuclei of stroma cells, whereas nuclear localization in glandular cells was restricted to Day 20. In pregnant endometrium collected when implantation was initiated (Day 20), FOXL2 was undetectable in the nuclei of stroma and glandular epithelium cells. Interestingly, FOXL2 has been reported to be the target for post-translational modifications, including sumoylation, acetylation, or phosphorylation, which are associated with changes in FOXL2 subcellular localization [54, 55] . In transfected cell lines, protein inhibitor of activated STAT-1 (PIAS1) has been shown to interact with FOXL2, leading to the sumoylation of FOXL2 by SUMO1 and UBC9, two proteins of sumoylation machinery [45, 56] . Using several mutated FOXL2 proteins, Marongiu et al. [45] also demonstrated that sumoylation site-mutated FOXL2 exhibited neither nuclear localization nor transcriptional activity. In the context of endometrium, sumoylation of proteins has been reported [57] and may represent a key process for the regulation of FOXL2 intracellular localization along the estrous cycle. Additional analyses of sumoylation machinery regulation (SUMO and PIAS proteins) will be required in order to validate this assumption, as well as to identify FOXL2 binding partners in mammalian endometrium.
In the context of ovarian development and physiology, microarray analyses and various experimental models have been used to identify FOXL2-regulated genes. Studies using human granulosa cell line (KGN) overexpressing FOXL2 [39] and Foxl2 knock-out mouse strains [26, 58] led to the identification of potential FOXL2 target genes including MNSOD/SOD2, RGS2, and COX2/PTGS2, which are known to be involved in apoptosis, stress response, gonadotropin responsiveness in granulosa cells, and ovulation [38, 59, 60] . Interestingly, these three FOXL2-regulated genes have also been unveiled in transcriptome analyses carried out with bovine endometrium collected from pregnant and nonpregnant females [13, 18] . PTGS2 has been well characterized in ruminant endometrium [61, 62] , and its expression is induced by pregnancy-associated factors such as IFNT. In ovine and baboon endometrium [63, 64] , SOD2 expression and regulation suggest that stimulation of SOD2 gene expression may improve pregnancy establishment by enhancing antioxidant defenses [65] . RGS2 expression has been shown to be restricted to implantation sites in the murine pregnant uterus [60] . In a FOXL2-overexpressing KGN cell line, PTGS2, SOD2, and RGS2 transcript expression was shown to be up-regulated [39] , whereas the ovarian expression of these three genes was downregulated in Foxl2 knock-out mouse strain [58] . On the other hand, in the endometrium, the high expression level reported for PTGS2, SOD2, and RGS2 is associated with a low level of FOXL2 during the establishment of pregnancy. The discrepancy between the regulation of these genes and FOXL2 levels according to the ovarian and endometrial context deserves to be further investigated in order to clarify the interplay between FOXL2 and its target genes as well as the contribution of this transcription factor in regulating the physiology of the endometrium, a key tissue for pregnancy outcome [66] .
Forkhead box genes have evolved to acquire specialized functions in various key biological processes [19] , and several members of this family such as FOXA1, FOXA2, and FOXO1 have been investigated in the human and murine uterus [19, 67] . A recent high-throughput study by Shimizu et al. [68] reported the expression of FOXA transcription factors in bovine endometrium, but, overall, the expression, regulation, and biological actions of FOX transcription factors have been poorly analyzed in the endometrium of ruminants. Using bovine endometrium collected during the estrous cycle and early pregnancy, the present study has demonstrated the expression, regulation, and cell localization of FOXL2, a gene first reported as an essential factor for ovarian differentiation [31, 36, 38] . In keeping with preliminary elements available from human endometrial gene profiles [49, 50] , our data provide strong arguments for the involvement of FOXL2 in regulating endometrial physiology and support this transcription factor as a key gene in female reproduction.
